Open AccessEfficacy and safety of pembrolizumab monotherapy in EGFR-mutant squamous cell lung cancer with PD-L1 over-expression: A case report
Author(s) -
Qiuxia Li,
Jianguo Wei,
Yiyi Chen,
Jianfang Wang
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030099
Subject(s) - medicine , pembrolizumab , lung cancer , epidermal growth factor receptor , pleural effusion , oncology , malignant pleural effusion , gefitinib , cancer , cancer research , pathology , immunotherapy